EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Is ibrutinib-related atrial fibrillation dose dependent? Insights from an individual case level analysis of the World Health Organization pharmacovigilance database

Joachim Alexandre iD, Jonaz Font, Da-Silva Angélique, Baptiste Delapierre, Ghandi Damaj iD, Anne-Flore Plane, Damien Legallois iD, Paul Milliez, Charles Dolladille iD, Basile Chrétien

Leukemia · 2024

DOI: 10.1038/s41375-024-02413-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Leukemia, 2024. Verfasst von Joachim Alexandre und 9 weiteren Autor:innen. Beteiligte Einrichtung: Normandie Univ, UNICAEN, INSERM U1086 ANTICIPE, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France. joachim.alexandre@unica…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Adenine, Pharmacovigilance, Piperidines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAdeninePharmacovigilancePiperidinesWorld Health OrganizationPyrazolesDatabases, FactualHumansMaleFemaleAgedMiddle AgedAdverse Drug Reaction Reporting SystemsDose-Response Relationship, DrugPyrimidinesAged, 80 and overProtein Kinase InhibitorsDrug-Related Side Effects and Adverse Reactions

Substanzen

ibrutinibAdeninePiperidinesPyrazolesPyrimidinesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Normandie Univ, UNICAEN, INSERM U1086 ANTICIPE, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France. joachim.alexandre@unicaen.fr.
  • Caen-Normandy University Hospital, PICARO Cardio-Oncology Program, Department of Pharmacology, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France. joachim.alexandre@unicaen.fr.
  • Normandie Univ, UNICAEN, INSERM U1086 ANTICIPE, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France.
  • Caen-Normandy University Hospital, Department of Cardiology, Avenue de la Côte de Nacre, F-14000, Caen, France.
  • Caen-Normandy University Hospital, PICARO Cardio-Oncology Program, Departments of Pharmacology and Medical Oncology, Avenue de la Côte de Nacre, F-14000, Caen, France.
  • Caen-Normandy University Hospital, Hematology Institute, Avenue de la Côte de Nacre, F-14000, Caen, France.

ORCID-Profile: Joachim Alexandre, Ghandi Damaj, Damien Legallois, Charles Dolladille

Zitieren

APA

Alexandre, J., Font, J., Angélique, D. S., Delapierre, B., Damaj, G., Plane, A. F., Legallois, D., Milliez, P., Dolladille, C., & Chrétien, B. (2024). Is ibrutinib-related atrial fibrillation dose dependent? Insights from an individual case level analysis of the World Health Organization pharmacovigilance database. Leukemia. https://doi.org/10.1038/s41375-024-02413-5

Vancouver

Alexandre J, Font J, Angélique DS, Delapierre B, Damaj G, Plane AF, et al. Is ibrutinib-related atrial fibrillation dose dependent? Insights from an individual case level analysis of the World Health Organization pharmacovigilance database. Leukemia. 2024. doi:10.1038/s41375-024-02413-5

BibTeX
@article{Alexandre2024,
  author = {Alexandre, Joachim and Font, Jonaz and Angélique, Da-Silva and Delapierre, Baptiste and Damaj, Ghandi and Plane, Anne-Flore and Legallois, Damien and Milliez, Paul and Dolladille, Charles and Chrétien, Basile},
  title = {Is ibrutinib-related atrial fibrillation dose dependent? Insights from an individual case level analysis of the World Health Organization pharmacovigilance database},
  journal = {Leukemia},
  year = {2024},
  doi = {10.1038/s41375-024-02413-5}
}
Kostenlos starten →